212 related articles for article (PubMed ID: 30336071)
41. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
[TBL] [Abstract][Full Text] [Related]
42. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
44. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Saatci O; Kaymak A; Raza U; Ersan PG; Akbulut O; Banister CE; Sikirzhytski V; Tokat UM; Aykut G; Ansari SA; Dogan HT; Dogan M; Jandaghi P; Isik A; Gundogdu F; Kosemehmetoglu K; Dizdar O; Aksoy S; Akyol A; Uner A; Buckhaults PJ; Riazalhosseini Y; Sahin O
Nat Commun; 2020 May; 11(1):2416. PubMed ID: 32415208
[TBL] [Abstract][Full Text] [Related]
45. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
[TBL] [Abstract][Full Text] [Related]
46. EMI2 expression as a poor prognostic factor in patients with breast cancer.
Vadhan A; Wang YY; Yuan SF; Lee YC; Hu SC; Huang JY; Ishikawa T; Hou MF
Kaohsiung J Med Sci; 2020 Aug; 36(8):640-648. PubMed ID: 32253818
[TBL] [Abstract][Full Text] [Related]
47. Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer.
Li Q; Qin T; Bi Z; Hong H; Ding L; Chen J; Wu W; Lin X; Fu W; Zheng F; Yao Y; Luo ML; Saw PE; Wulf GM; Xu X; Song E; Yao H; Hu H
Nat Commun; 2020 Mar; 11(1):1456. PubMed ID: 32193458
[TBL] [Abstract][Full Text] [Related]
48. CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis.
Zhao B; Song X; Guan H
Life Sci; 2020 Mar; 244():117179. PubMed ID: 31863774
[TBL] [Abstract][Full Text] [Related]
49. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death.
Liu J; Yao L; Zhang M; Jiang J; Yang M; Wang Y
Aging (Albany NY); 2019 Sep; 11(18):7830-7846. PubMed ID: 31553952
[TBL] [Abstract][Full Text] [Related]
51. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
Hua Q; Jin M; Mi B; Xu F; Li T; Zhao L; Liu J; Huang G
J Hematol Oncol; 2019 Sep; 12(1):91. PubMed ID: 31488218
[TBL] [Abstract][Full Text] [Related]
52. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
[TBL] [Abstract][Full Text] [Related]
54. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
[TBL] [Abstract][Full Text] [Related]
55. Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases.
Li X; Fang Y; Jiang D; Dong Y; Liu Y; Zhang S; Guo J; Qi C; Zhao C; Jiang F; Jin Y; Geng J; Yang C; Zhang H; Wei B; Liang J; Wang C; Dai H; Zhou H; Jiang D; Ning W
Mol Ther; 2021 Jan; 29(1):347-364. PubMed ID: 33007201
[TBL] [Abstract][Full Text] [Related]
56. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.
Loh JJ; Li TW; Zhou L; Wong TL; Liu X; Ma VWS; Lo CM; Man K; Lee TK; Ning W; Tong M; Ma S
Cancer Res; 2021 Nov; 81(22):5692-5705. PubMed ID: 34551961
[TBL] [Abstract][Full Text] [Related]
57. FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival.
Wu M; Ding Y; Wu N; Jiang J; Huang Y; Zhang F; Wang H; Zhou Q; Yang Y; Zhuo W; Teng L
Am J Cancer Res; 2021; 11(3):712-728. PubMed ID: 33791149
[TBL] [Abstract][Full Text] [Related]
58. Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
Ogiwara Y; Nakagawa M; Nakatani F; Uemura Y; Zhang R; Kudo-Saito C
Cancer Lett; 2022 Jul; 537():215690. PubMed ID: 35439537
[TBL] [Abstract][Full Text] [Related]
59. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.
Rao J; Wang H; Ni M; Wang Z; Wang Z; Wei S; Liu M; Wang P; Qiu J; Zhang L; Wu C; Shen H; Wang X; Cheng F; Lu L
Gut; 2022 Dec; 71(12):2539-2550. PubMed ID: 35140065
[TBL] [Abstract][Full Text] [Related]
60. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
